These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4044141)

  • 1. Protein-binding and urinary excretion of 99mTc(Sn)-MDP and 99mTc-MDP.
    Savelkoul TJ; van Ginkel JJ; Grouls RJ; Oldenburg SJ; Duursma SA
    Int J Nucl Med Biol; 1985; 12(2):125-31. PubMed ID: 4044141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of 99mTc(Sn)-MDP complexes to human serum albumin and other blood proteins determined with gel chromatography and ultrafiltration.
    Huigen YM; Tji TG; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum A; 1989; 40(7):629-35. PubMed ID: 2551860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of 99mTc(113Sn)-MDP to human serum albumin. The influence of various technetium, tin, and MDP concentrations.
    Grouls RJ; Oldenburg SJ; Savelkoul TJ; Dröge JH
    Int J Rad Appl Instrum B; 1987; 14(2):127-32. PubMed ID: 3597113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrolytically labeled [99mTc]MDP: chromatographic pattern, stability and biodistribution in rats.
    Savelkoul TJ; Oldenburg SJ; Van Oort WJ; Duursma SA
    Int J Appl Radiat Isot; 1984 Aug; 35(8):709-13. PubMed ID: 6237064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc bone scanning agents--VI. Gel chromatographic analysis of the plasma protein binding of 99mTc(Sn)pyrophosphate, 99mTc(Sn)MDP and 99mTc(Sn)HMDP.
    Kroesbergen J; Roozen AM; Wortelboer MR; Gelsema WJ; de Ligny CL
    Int J Rad Appl Instrum B; 1988; 15(5):479-87. PubMed ID: 3254872
    [No Abstract]   [Full Text] [Related]  

  • 6. A micro-autoradiographical study of the localization of 99mTc(Sn)-MDP and 99mTc-MDP in undecalcified bone sections.
    Savelkoul TJ; Visser WJ; Oldenburg SJ; Duursma SA
    Eur J Nucl Med; 1986; 11(11):459-62. PubMed ID: 3086099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of ultrafiltration as a method of measuring free 99mTc-MDP.
    Moore AE; Hain SF; Blake GM; Fogelman I
    J Nucl Med; 2003 Jun; 44(6):891-7. PubMed ID: 12791815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study to determine the dependence of 99mTc-MDP protein binding on plasma clearance and serum albumin concentration.
    Moore AE; Blake GM; Fogelman I
    Nucl Med Commun; 2007 Mar; 28(3):187-92. PubMed ID: 17264777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 99mTc bone scanning agents--III. Preparation and gel chromatography of 99mTc(Sn)MDP complexes.
    Kroesbergen J; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):419-24. PubMed ID: 3710704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gel-chromatographic analysis of 99mTc-labeled human serum albumin prepared with Sn(II) as the reductant.
    Dekker BG; Arts CJ; De Ligny CL
    Int J Appl Radiat Isot; 1982 Dec; 33(12):1351-7. PubMed ID: 6220978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-MDP retention in osteoporosis: relationship to other indices of bone cell activity and response to calcium and vitamin D therapy.
    Davie MW; Britton JM; Haddaway M; McCall IW
    Eur J Nucl Med; 1987; 13(9):462-6. PubMed ID: 3440471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bone metabolism in thalassemic children with multiple transfusions. Compartmental analysis of 99mTc-Sn-MDP kinetics].
    Mele M; De Mattia D; D'Addabbo A; Schettini F; Lauriero F; Rubini G
    Radiol Med; 1989 Nov; 78(5):455-60. PubMed ID: 2608933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative studies of bone using (18)F-fluoride and (99m)Tc-methylene diphosphonate: evaluation of renal and whole-blood kinetics.
    Park-Holohan SJ; Blake GM; Fogelman I
    Nucl Med Commun; 2001 Sep; 22(9):1037-44. PubMed ID: 11505214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyclophosphamide on the binding of 99mTcO-4 and 99mTc-MDP to blood cells and plasma proteins.
    Santos JS; de-Paula EF; Correa TG; de-Freitas LC; da-Fonseca LM; Gutfilen B; Bernardo-Filho M
    Braz J Med Biol Res; 1995 Jan; 28(1):131-5. PubMed ID: 7581022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of 99mTc-MDP and 99mTc-pertechnetate by computerized quantitative joint scintigraphy.
    Oka M; Möttönen T; Rekonen A
    Scand J Rheumatol; 1983; 12(1):46-8. PubMed ID: 6300996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
    Degrossi OJ; Oliveri P; García del Río H; Labriola R; Artagaveytía D; Degrossi EB
    J Nucl Med; 1985 Oct; 26(10):1135-9. PubMed ID: 4045556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A direct in vivo measurement of 99mTc-methylene diphosphonate protein binding.
    Blake GM; Moore AE; Park-Holohan SJ; Fogelman I
    Nucl Med Commun; 2003 Jul; 24(7):829-35. PubMed ID: 12813203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro effect of cyclophosphamide on the binding of radiopharmaceuticals (99mTcO4- and 99mTc-MDP) to blood elements.
    Ripoll-Hamer E; Freitas LC; De-Paula EF; Fonseca LM; Gutfilen B; Bernardo-Filho M
    Braz J Med Biol Res; 1995 Feb; 28(2):256-60. PubMed ID: 7581051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-MDP uptake and histological changes during rat bone marrow regeneration.
    Chisin R; Gazit D; Ulmansky M; Laron A; Atlan H; Sela J
    Int J Rad Appl Instrum B; 1988; 15(4):469-76. PubMed ID: 3255743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the oxidation state of 99mTc in complexes with MDP and DTPA.
    Handeland AM; Sundrehagen E
    Int J Rad Appl Instrum A; 1987; 38(6):479-84. PubMed ID: 3038791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.